1-3 of 3
Ramon Salazar
Close
Sort by
Journal Articles

Phase I Clinical Trial to Evaluate the Safety of Baricitinib to Prevent Respiratory Insufficiency Progression in Oncohematological Patients Affected with COVID-19 - BARCOVID19 Study

Gabriela Sanz-Linares, Alberto Mussetti, Adaia Albasanz-Puig, Iñaki Salvador-Corre, Anna Sureda, Carlota Gudiol, Ramon Salazar, Mar Marin, Margarita García Martín, Valentin Navarro, Irma De la Haba, Eva Coma, Xavier Dura, Sandra Fontanals, Gala Serrano, Claudia Cruz, Rafael Mañez, Gabriel Moreno-González
Journal: Blood
Blood (2022) 140 (Supplement 1): 10750–10751.
https://doi.org/10.1182/blood-2022-159213
Published: 2022
Journal Articles

Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death

Ana Domostegui, Suresh Peddigari, Carol A. Mercer, Flavia Iannizzotto, Marta L. Rodriguez, Marta Garcia-Cajide, Virginia Amador, Sarah T. Diepstraten, Gemma L. Kelly, Ramón Salazar, Sara C. Kozma, Eric P. Kusnadi, Jian Kang, Antonio Gentilella, Richard B. Pearson, George Thomas, Joffrey Pelletier
Journal: Blood
Blood (2021) 137 (24): 3351–3364.
https://doi.org/10.1182/blood.2020007452
Published: 2021
Includes: Supplemental data
Journal Articles

Prospective Multicentric Observational Study of COVID19 in Oncohematological Patients in the Catalonia Region: The Opposite Effect of Steroids on Survival

Alberto Mussetti, MD, Clara Maluquer, Cristian Tebe Cordomi, Maria Condom, MD, Kevin Molina-Mata, Juan Antonio Marin Jimenez, Jose Carlos Tapia Tapia, Javier Gavira Diaz, Margarita Majem Tarruella, Felip Falgas, Laia Llobera Rius, Roser Fort Culillas, Lucia Llavata Martí, Miriam Moreno, MD, Susana Vives, MD, Rosa Coll, MD, Silvia Martin Batista, Carme Talarn, Miguel Sagüés, Ali Bazarbachi, MD PhD, Ramon Salazar, Anna Sureda Balari, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–35.
https://doi.org/10.1182/blood-2020-138809
Published: 2020